Financial news
The newsroom
Headlines from the Federal Reserve, ECB, Bank of Japan, Bank of England, SEC EDGAR, the White House and the DOJ. Context notes are written automatically by software from each headline, not by an editor. They are neutral and information-only, Kresmion publishes no buy or sell recommendations.
Public RSS feeds · refreshed every 30 minutes
8078 items from SEC EDGAR · clear filters
- 8-K - Definium Therapeutics, Inc. (0001813814) (Filer)
Automated noteDefinium Therapeutics, Inc. filed a Form 8-K with the SEC on September 14, 2026 (Accession No. 0001104659-26-107275), containing a Regulation FD disclosure, other events, and accompanying financial statements and exhibits.
- 8-K - Thryv Holdings, Inc. (0001556739) (Filer)
Automated noteThryv Holdings, Inc. filed a Form 8-K on September 14, 2026, reporting entry into a material definitive agreement and including its financial statements and related exhibits.
- 8-K - Cabaletta Bio, Inc. (0001759138) (Filer)
Automated noteCabaletta Bio, Inc. filed a Form 8-K with the SEC on September 14, 2026, reporting an Item 8.01 “Other Events” disclosure (Accession No. 0001759138-26-000041, 154 KB).
- 8-K - Piedmont Realty Trust, Inc. (0001042776) (Filer)
Automated notePiedmont Realty Trust, Inc. filed a Form 8-K on September 14 2026 (Accession No. 0001193125-26-389860), reporting Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits.
- 8-K - Scholar Rock Holding Corp (0001727196) (Filer)
Automated noteScholar Rock Holding Corp filed a Form 8-K on September 14, 2026 (Accession No. 0001104659-26-107273), containing a Regulation FD disclosure, other events, and accompanying financial statements and exhibits.
- 8-K - Sphere 3D Corp. (0001591956) (Filer)
Automated noteSphere 3D Corp. filed a Form 8-K with the SEC on September 14, 2026, including a Regulation FD disclosure (Item 7.01) and accompanying financial statements and exhibits (Item 9.01).
- 8-K - Telomir Pharmaceuticals, Inc. (0001971532) (Filer)
Automated noteTelomir Pharmaceuticals filed a Form 8-K with the SEC on September 14, 2026, containing a Regulation FD disclosure and accompanying financial statements and exhibits.
- 8-K - Strategy Inc (0001050446) (Filer)
Automated noteStrategy Inc. submitted a Form 8-K on September 14, 2026 (Accession No. 0001193125-26-389858), containing a Regulation FD disclosure and a report of other events.
- 8-K - NRX Pharmaceuticals, Inc. (0001719406) (Filer)
Automated noteNRX Pharmaceuticals filed a Form 8-K on September 14, 2026, including a Regulation FD disclosure and accompanying financial statements and exhibits.
- 8-K - WESTERN DIGITAL CORP (0000106040) (Filer)
Automated noteWestern Digital Corp filed a Form 8-K on September 14, 2026, containing a Regulation FD disclosure, other events, and financial statements with accompanying exhibits.
- 8-K - PERDOCEO EDUCATION Corp (0001046568) (Filer)
Automated notePerdoCEO Education Corp filed a Form 8-K on September 14, 2026, reporting entry into a material definitive agreement, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K - Strive, Inc. (0001920406) (Filer)
Automated noteStrive, Inc. filed a Form 8-K with the SEC on September 14, 2026, reporting an Item 8.01 Other Events disclosure (Accession No. 0001628280-26-061682).
- 8-K - AirJoule Technologies Corp. (0001855474) (Filer)
Automated noteAirJoule Technologies Corp. filed a Form 8-K on September 14, 2026 reporting a material definitive agreement, unregistered sales of equity securities, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K - KEYCORP /NEW/ (0000091576) (Filer)
Automated noteKeyCorp filed a Form 8-K on September 14, 2026, containing a Regulation FD disclosure and accompanying financial statements and related exhibits.
- 8-K - National Healthcare Properties, Inc. (0001561032) (Filer)
Automated noteNational Healthcare Properties, Inc. filed a Form 8-K on September 14, 2026, disclosing director/officer departures, elections, appointments and related compensation arrangements, and providing its financial statements and accompanying exhibits.
- 8-K - TEXAS CAPITAL BANCSHARES INC/TX (0001077428) (Filer)
Automated noteTexas Capital Bancshares Inc. filed a Form 8-K on September 14, 2026, disclosing a notice of delisting or failure to satisfy a continued listing rule and a transfer of listing, accompanied by Regulation FD disclosure and financial statements.
- 8-K - PBF Energy Inc. (0001534504) (Filer)
Automated notePBF Energy Inc. filed a Form 8-K on September 14, 2026, containing a Regulation FD disclosure, other events, and related financial statements and exhibits.
- 8-K - PBF Holding Co LLC (0001566011) (Filer)
Automated notePBF Holding Co LLC filed a Form 8-K on September 14, 2026 (Accession No. 0001193125-26-389847), containing a Regulation FD disclosure, other events, and accompanying financial statements and exhibits.
- 8-K - VisionWave Holdings, Inc. (0002038439) (Filer)
Automated noteVisionWave Holdings, Inc. filed a Form 8-K on September 14, 2026, including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - Soluna Holdings, Inc (0000064463) (Filer)
Automated noteSoluna Holdings filed a Form 8-K on September 14, 2026, containing a Regulation FD disclosure and accompanying financial statements and exhibits.
- 8-K - Cullinan Therapeutics, Inc. (0001789972) (Filer)
Automated noteCullinan Therapeutics, Inc. filed a Form 8-K on September 14, 2026, containing a Regulation FD disclosure, other events, and related financial statements and exhibits.
- 8-K - NPK International Inc. (0000071829) (Filer)
Automated noteNPK International Inc. filed a Form 8-K reporting the departure and appointment of certain directors and officers, related compensatory arrangements, and included its financial statements and accompanying exhibits.
- 8-K - Solid Power, Inc. (0001844862) (Filer)
Automated noteSolid Power, Inc. filed a Form 8-K on September 14, 2026, including a Regulation FD disclosure and accompanying financial statements and exhibits.
- 8-K - Q32 Bio Inc. (0001661998) (Filer)
Automated noteQ32 Bio Inc. filed a Form 8-K on September 14, 2026, including a Regulation FD disclosure, other events, and financial statements and exhibits.
- 8-K - FrontView REIT, Inc. (0001988494) (Filer)
Automated noteFrontView REIT, Inc. filed a Form 8-K on September 14, 2026, containing a Regulation FD disclosure and the company’s financial statements and related exhibits.
- 8-K - Immunocore Holdings plc (0001671927) (Filer)
Automated noteImmunocore Holdings plc filed a Form 8-K on September 14, 2026, containing a Regulation FD disclosure and accompanying financial statements and exhibits.
- 8-K - Armata Pharmaceuticals, Inc. (0000921114) (Filer)
Automated noteArmata Pharmaceuticals, Inc. filed a Form 8-K on September 14, 2026, containing a Regulation FD disclosure (Item 7.01) and its financial statements and related exhibits (Item 9.01).
- 8-K - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Filer)
Automated noteCorbus Pharmaceuticals filed a Form 8-K on September 14, 2026, containing a Regulation FD disclosure, other events, and accompanying financial statements and exhibits.
- 8-K - Bally's Corp (0001747079) (Filer)
Automated noteBally's Corp filed a Form 8-K reporting entry into a material definitive agreement, the creation of a direct financial obligation or off-balance-sheet arrangement, other events, and accompanying financial statements and exhibits.
- 8-K - FLOWSERVE CORP (0000030625) (Filer)
Automated noteFlowserve Corp filed a Form 8-K on September 14, 2026, reporting director and officer departures, elections, appointments and related compensation arrangements, providing a Regulation FD disclosure, and attaching financial statements and related exhibits.